Utilizing Endocannabinoid Alterations to Target Different Populations for Treatment
- Exploring CB1 receptor availability, potentially contributing to heightened stress reactivity and increased risk of relapse in opioid-use disorder
- Establishing clinical relevance and explore endocannabinoid modulation as a treatment strategy
- Understanding what population is a better target to use in clinical trial for endocannabinoid modulation